2021 annual financial data
MaxCyte, Inc. 2021 Operating cash flow margin
MaxCyte, Inc. 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -31.51%.
Operating income was -18,188,600 USD and net income was -19,082,200 USD.
Operating cash flow was -10,679,600 USD.
Get free MaxCyte, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,894,100 USD
- Operating income
- -18,188,600 USD
- Net income
- -19,082,200 USD
- Operating cash flow
- -10,679,600 USD